Predictors of primary breast cancers responsiveness to preoperative epirubicin/cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures
about
CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancerSurface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.Multivariate meta-analysis of proteomics data from human prostate and colon tumours.The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis.Fecal microbiome analysis as a diagnostic test for diverticulitis.Gene expression of circulating tumour cells in breast cancer patientsExpression biomarkers for clinical efficacy and outcome prediction in cancer.Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer.Breast cancer expression profiling: the impact of microarray testing on clinical decision making.Whole genome expression analysis for biologic rational pathway modeling: application in cancer prognosis and therapy prediction.Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.Genomic predictors of outcome and treatment response in breast cancer.Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy.Investigation of Archived Formalin-Fixed Paraffin-Embedded Pancreatic Tissue with Whole-Genome Gene Expression Microarray
P2860
Q33256427-0E17FCFB-ABE5-4195-80ED-6C86E5C09453Q33338626-A5FDD165-0A72-41AE-BE85-30CD9F03A644Q33694799-1AFF1DAD-7413-473A-8522-CCE1AF870C5BQ35012807-130DA4D4-8E91-4492-9E57-E9AB94B245C3Q35181039-30A5053C-169C-4A07-8F53-033A29652F74Q35960074-E7672D61-5122-46EE-AAC0-BDB35510A438Q36341754-C912FAAF-F8A4-4797-9429-B310A1F8C616Q36419147-BB62C1D4-A03B-46D9-93B6-D11E83ADFEE9Q36613933-BA4193A7-EF27-4ED6-A674-F5D4DA731403Q36615223-B7369BDA-1D0A-4E3C-BDD9-AA236E5E64A0Q36816034-93F67563-8B14-4A6C-9A6C-366157EC4ACBQ37523889-E1963E7E-8450-4946-A497-2B0A0745B61EQ41896118-545BB62D-C5CE-4138-B0DE-7D40EADB0BC2Q58689165-9EB88863-DC03-4BB1-942E-0C4A8F3784E9
P2860
Predictors of primary breast cancers responsiveness to preoperative epirubicin/cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Predictors of primary breast c ...... y useful predictive signatures
@ast
Predictors of primary breast c ...... y useful predictive signatures
@en
Predictors of primary breast c ...... y useful predictive signatures
@nl
type
label
Predictors of primary breast c ...... y useful predictive signatures
@ast
Predictors of primary breast c ...... y useful predictive signatures
@en
Predictors of primary breast c ...... y useful predictive signatures
@nl
prefLabel
Predictors of primary breast c ...... y useful predictive signatures
@ast
Predictors of primary breast c ...... y useful predictive signatures
@en
Predictors of primary breast c ...... y useful predictive signatures
@nl
P2093
P2860
P356
P1476
Predictors of primary breast c ...... y useful predictive signatures
@en
P2093
Hans Bojar
Hans-Bernd Prisack
Marc Munnes
Olga Modlich
Werner Audretsch
P2860
P2888
P356
10.1186/1479-5876-3-32
P407
P577
2005-08-09T00:00:00Z
P5875
P6179
1011508499